Lab antibody, antiviral research aids COVID-19 response

Lawrence Livermore National Laboratory (LLNL) scientists are contributing to the global fight against COVID-19 by combining artificial intelligence/machine learning, bioinformatics and supercomputing to help discover candidates ...

The truth about misinformation

In today's fast-paced digital age, information can become outdated rapidly and people must constantly update their memories. But changing our previous understanding of the news we hear or the products we use isn't always ...

Turning wood into pharmaceutical ingredients

Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry. Typically, large amounts of flammable solvents are used during these processes, which usually require several steps ...

Fungus produces highly effective surfactant

Mortierella alpina lives in the soil and likes to keep cool. This fungus, which belongs to the zygomycetes, grows best at temperatures of 10 to 15 degrees C and occurs mainly in alpine or arctic habitats. In biotechnology, ...

How AI could spur drug development

Using artificial intelligence in drug design would give pharmaceutical research a boost, says Gisbert Schneider. In the medium term, computers could even carry out experiments autonomously.

Drug diversity in bacteria

Bacteria produce a cocktail of various bioactive natural products in order to survive in hostile environments with competing (micro)organisms. In the current issue of Nature Chemical Biology, researchers at Goethe University ...

Chemical noses to detect and rid pollutants

Scientists across Europe are joining forces to develop next-gen "chemical noses" that will detect and rid pollutants from the environment as part of a collaborative €2.9 million Horizon2020 FET-OPEN project (INITIO) that ...

page 14 from 22